Wikidata

(Q63340769)

English

Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.

clinical trial

In more languages

Statements

title
Open-Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine SR in Canadian Subjects With Multiple Sclerosis Who Participated in Acorda Extension Trials (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Canada
0 references
start time
December 2010
0 references
end time
June 2012
0 references
number of participants
38
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63340769&oldid=1876988329"